U.S. Markets close in 1 hr 39 mins

Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
30.83+0.14 (+0.46%)
At close: 03:04PM CST

Zhejiang Dayang Biology Technology Co.,Ltd.

No. 22 Chaoyang Road
Dayang Town
Jiande 311616
86 57 1641 56812

Sector(s)Basic Materials
Full Time Employees925

Key Executives

NameTitlePayExercisedYear Born
Mr. Yanggui ChenGM & ChairmanN/AN/A1952
Mr. Xianyu WangExec. Deputy GM & Vice ChairmanN/AN/A1960
Ms. Xujun ChenFinancial DirectorN/AN/A1978
Mr. Weijun GuanDeputy GM & DirectorN/AN/A1964
Mr. Yongsheng QiuDeputy GM & DirectorN/AN/A1960
Mr. Xuping XuBoard Sec.N/AN/A1965
Mr. Xueming QianChief EngineerN/AN/A1964
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Zhejiang Dayang Biology Technology Co.,Ltd. engages in research and development, production, and sale of biological products, agricultural chemicals, and chemical in China. The company's products include food additive potassium carbonate, potassium carbonate, food additive potassium bicarbonate, potassium bicarbonate, agricultural grade ammonium chloride, and industrial grade ammonium chloride. It also offers chemical products, such as 2-chloro-6-fiuorobenzaldehyde, 2-chloro-6-fluorobenzyl chloride, and anisole products; veterinary APIs, including amprolium HCL; and veterinary drug premixes comprising enramycin premixes. Zhejiang Dayang Biology Technology Co.,Ltd. was founded in 1976 and is based in Jiande, China.

Corporate Governance

Zhejiang Dayang Biology Technology Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.